Table 2.

(A) Pre-transplant characteristics of patients who died in the first trimester after heart transplantation vs. alive patients. (B) Logistic regression multivariate analysis of factors associated with mortality in the first trimester after heart transplantation.

(A) Pre-transplant characteristics	Dead N = 23		Alive N = 128		P-value
Variable	N/median	%/IQR	N/median	%/IQR
Sex (female)	8	(34.8%)	20	(15.6%)	0.030
Age	52	42.3–61.0	51	39.0–58.5	N.S.
Body mass index	23.7	20.7–27.9	24.5	22.0–26.6	N.S.
IgA aB2GP1 positive and B2A-CIC positive	8	(34.8%)	11	(8.6%)	<0.001
IgA aB2GP1 positive and B2A-CIC negative	5	(21.7%)	23	(18%)	N.S.
Blood type
Group 0	7	(30.4%)	61	(47.7%)	N.S.
Group A	15	(65.2%)	48	(37.5%)	0.013
Group B	1	(4.3%)	14	(10.9%)	N.S.
Group AB	0	(0%)	5	(3.9%)	N.S.
Rh positive	21	(91.3%)	107	(83.6%)	N.S.
Other pathologies and risk factors
Renal dysfunction	5	(21.7%)	23	(18%)	N.S.
HTA antecedents	5	(21.7%)	38	(29.7%)	N.S.
Diabetes	3	(13%)	29	(22.7%)	N.S.
Dyslipidemia	8	(34.8%)	41	(32%)	N.S.
Hyperuricemia	1	(4.3%)	17	(13.3%)	N.S.
Hyperbilirubinemia	9	(39.1%)	25	(19.5%)	N.S.
ALT/AST High levels	3	(13%)	34	(26.6%)	N.S.
Active smoker	7	(30.4%)	28	(21.9%)	N.S.
Ex-smoker	5	(21.7%)	36	(28.1%)	N.S.
No-smoking	11	(47.8%)	64	(50%)	N.S.
Patients with thrombotic antecedents	1	(4.3%)	6	(5.8%)	N.S.
Previously anticoagulated	15	(65.2%)	69	(53.9%)	N.S.
Other vascular diseases
Thrombosis A/V	1	(4.3%)	8	(6.3%)	N.S.
Thrombophlebitis	0	(0%)	2	(1.6%)	N.S.
Ethnicity Caucasian	22	(95.7%)	123	(96.1%)	N.S.
Ethnicity: others	1	(4.3%)	5	(3.9%)	N.S.
(B) Multivariate analysis	Univariate		Multivariate
Variable	OR	95% CI OR	OR	95% CI OR	P-value
B2A-CIC positive	5.67	1.97–16.33	6.13	1.93–19.40	0.002
Sex (female)	2.88	1.08–7.67	4.18	1.35–12.94	0.013
Blood type: Group A	3.13	1.23–7.92	4.05	1.44–11.43	0.008

IQR, interquartile range; N.S., not significant.